Capstone Investment Advisors, LLC Biogen Inc. Transaction History

Capstone Investment Advisors, LLC

$30.4 Billion
Q3 2024

A detailed history of Capstone Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Capstone Investment Advisors, LLC holds 19,446 shares of BIIB stock, worth $2.92 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,446

Previous 6,573 195.85%

Holding current value

$2.92 Million

Previous $1.52 Million 147.47%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $2.43 Million - $3.05 Million	12,873 Added 195.85%	19,446 $3.77 Million
Q2 2024 Aug 14, 2024	SELL	$190.52 - $236.72 $820,760 - $1.02 Million	-4,308 Reduced 39.59%	6,573 $1.52 Million
Q1 2024 May 01, 2024	BUY	$212.02 - $267.71 $1.21 Million - $1.52 Million	5,691 Added 109.65%	10,881 $2.35 Million
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $158,929 - $191,309	-714 Reduced 12.09%	5,190 $1.34 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $935,436 - $1.06 Million	3,693 Added 167.03%	5,904 $1.52 Million
Q2 2023 Aug 10, 2023	SELL	$275.25 - $318.06 $343,787 - $397,256	-1,249 Reduced 36.1%	2,211 $629,000
Q1 2023 May 09, 2023	BUY	$256.56 - $292.34 $887,697 - $1.01 Million	3,460 New	3,460 $961,000
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $853,119 - $1.01 Million	-4,549 Reduced 93.05%	340 $69,000
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $2.65 Million - $3.34 Million	-13,668 Reduced 73.65%	4,889 $1.03 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $1.67 Million - $2.14 Million	7,438 Added 66.89%	18,557 $4.45 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.18 Million - $1.53 Million	4,153 Added 59.62%	11,119 $3.15 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $3.08 Million - $4.93 Million	-11,876 Reduced 63.03%	6,966 $2.41 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $3.57 Million - $5.38 Million	15,119 Added 406.1%	18,842 $4.61 Million
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $668,014 - $771,306	-2,523 Reduced 40.39%	3,723 $1.06 Million
Q2 2020 Aug 14, 2020	BUY	$258.66 - $342.55 $1.54 Million - $2.04 Million	5,943 Added 1961.39%	6,246 $1.67 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $5.01 Million - $6.93 Million	-22,781 Reduced 98.69%	303 $90,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $1.05 Million - $1.17 Million	-4,814 Reduced 17.26%	23,084 $5.37 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $381,345 - $420,351	-1,739 Reduced 5.87%	27,898 $6.53 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $5.96 Million - $9.32 Million	27,492 Added 1281.68%	29,637 $7.01 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $331,972 - $420,478	-1,192 Reduced 35.72%	2,145 $645,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $420,012 - $549,260	1,431 Added 75.08%	3,337 $1.18 Million
Q2 2018 Aug 13, 2018	BUY	$257.52 - $306.91 $490,833 - $584,970	1,906 New	1,906 $553,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Account

Capstone Investment Advisors, LLC Biogen Inc. Transaction History